menu search

MEDP / Medpace: Resilience During The Down Cycle

Medpace: Resilience During The Down Cycle
Medpace Holdings, a Clinical Research Organisation (CRO), has outperformed in the stock market with a return of 429% in the last five years compared to 62% for SPY. CROs, which develop clinical studies for pharma companies, have benefited from increased funding for clinical studies, particularly during the search for COVID vaccines. Despite a drop in biotech funding in 2021 and 2022, recent months have seen a sharp increase in funding levels, indicating a positive outlook for the industry and companies like Medpace. Read More
Posted: Jul 20 2023, 09:00
Author Name: Seeking Alpha
Views: 112922

MEDP News  

Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

By Zacks Investment Research
November 1, 2023

Is Medpace (MEDP) Outperforming Other Medical Stocks This Year?

Here is how Medpace (MEDP) and Acadia Pharmaceuticals (ACAD) have performed compared to their sector so far this year. more_horizontal

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

By Zacks Investment Research
October 26, 2023

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes. more_horizontal

Medpace (MEDP) Upgraded to Buy: Here's What You Should Know

By Zacks Investment Research
October 26, 2023

Medpace (MEDP) Upgraded to Buy: Here's What You Should Know

Medpace (MEDP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). more_horizontal

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

By Zacks Investment Research
October 23, 2023

Medpace (MEDP) Q3 Earnings and Revenues Beat Estimates

Medpace (MEDP) came out with quarterly earnings of $2.22 per share, beating the Zacks Consensus Estimate of $2.04 per share. This compares to earnings more_horizontal

Are Medical Stocks Lagging Medpace (MEDP) This Year?

By Zacks Investment Research
October 13, 2023

Are Medical Stocks Lagging Medpace (MEDP) This Year?

Here is how Medpace (MEDP) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year. more_horizontal

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think

By Zacks Investment Research
September 25, 2023

Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think "Yes"

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal

Medpace: A Great Anchor For A Long-Term Portfolio

By Seeking Alpha
September 9, 2023

Medpace: A Great Anchor For A Long-Term Portfolio

Medpace is a Contract Research Organization (CRO) that provides outsourced clinical development services to the biotech, pharma, and medical device in more_horizontal

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

By Zacks Investment Research
September 8, 2023

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

Medpace (MEDP) is well positioned to outperform the market, as it exhibits above-average growth in financials. more_horizontal


Search within

Pages Search Results: